Abstract
PCR thermocycler, ROTOR-GENE Q 5 PLEX HRM PLAFORM, polymerase chain reaction, with real-time detection time (AU)
Universidade Estadual de Campinas (UNICAMP). Centro de Hematologia e Hemoterapia (HEMOCENTRO) (Institutional affiliation for the last research proposal) Birthplace: Brazil
bachelor's at Medicina from Pontifícia Universidade Católica de Campinas (1981) and doctorate at Clinical Medicine from Universidade Estadual de Campinas (1989). He is currently full professor at Universidade Estadual de Campinas. Has experience in Medicine, focusing on Hematology, acting on the following subjects: venous thrombosis, myocardial infarction, factor viii, coagulação and polymorphisms. (Source: Lattes Curriculum)
News published in Agência FAPESP Newsletter about the researcher |
TITULO |
Articles published in other media outlets (0 total): |
More itemsLess items |
VEICULO: TITULO (DATA) |
VEICULO: TITULO (DATA) |
PCR thermocycler, ROTOR-GENE Q 5 PLEX HRM PLAFORM, polymerase chain reaction, with real-time detection time (AU)
Automated optical microscopy system designed to work inside the CO2 incubator. It allows the monitoring of cell culture, with analysis of the images in real time. It allows the analysis of chemotaxis, proliferation, apoptosis, invasion and cell migration, and angiogenesis assays. (AU)
Thromboembolic disorders represent a major culprit for morbidity-mortality in Brazil and the World. The Hemocentro at Unicamp has a scientifically recognized research group, with over 100 highly cited publications in this field. We have revealed the roles of FVIII, VWF and of ADAMTS13 in Deep Venous Thrombosis (DVT) and severe Post-Thrombotic Syndrome (PTS); the association between hyperc…
About 30% of patients with deep vein thrombosis (DVT) do not present the classic risk factors associated with the onset of the disease, and the molecular mechanisms of DVT remain unclear. Therefore, there is a clear need to investigate new biomarkers that may be associated with this disease, as well as new studies to elucidate the mechanisms that lead to pathogenesis. According to Virchow…
Deep vein thrombosis (DVT) is a major public health problem. It is estimated that the annual incidence of DVT is 67 per 100,000 individuals in the general population. The treatment of DVT is based on the use of anticoagulants and intended to prevent complications of the disease. The complications of DVT are thrombus progression and embolization, which can cause death of the patient. Late …
Venous Thromboembolism (VTE) is a complex disease that affects 1:1000 individuals worldwide and whose etiology lays on the interaction of genetic and acquired factors. Although many risk factors for VTE are well defined, at least 30% of cases are still idiopathic, raising suspicions of the existence of other etiologic factors yet unknown. Furthermore, individuals with hereditary or acquir…
(Only some records are available in English at this moment)
(Only some records are available in English at this moment)
Deep venous thrombosis (DVT) is a relatively common, multifactorial disease, triggered by acquired or spontaneous factors. Since the molecular bases of DVT have not yet been fully unraveled, the activities and roles of biomolecules, metabolites of up to 1,200 Da, and blood cells are occupying become attractive subjects in medical scientific field. Our project aims to study metabolites inv…
(Only some records are available in English at this moment)
3 / 3 | Ongoing research grants |
18 / 11 | Completed research grants |
5 / 5 | Ongoing scholarships in Brazil |
52 / 24 | Completed scholarships in Brazil |
78 / 43 | All research grants and scholarships |
Associated processes |